As of September 2024, Lumosa Therapeutics has a market cap of $1.30B. This makes Lumosa Therapeutics the world's 6737th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $814.59M | 132.06% |
2023 | $351.02M | 73.35% |
2022 | $202.49M | -2.11% |
2021 | $206.86M | 14.18% |
2020 | $181.16M | 2.47% |
2019 | $176.79M | 12.97% |
2018 | $156.49M | 3.22% |
2017 | $151.61M | -33.33% |
2016 | $227.42M | -47.32% |
2015 | $431.66M | - |